Workflow
CBIZ(CBZ) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Company Overview - CBIZ has over 10,000 employees and serves over 135,000 clients[12] - The company's pro forma revenue is approximately $2.8 billion[12] - The client retention rate is approximately 90%[12] - Recurring services account for approximately 72% of revenue, while project-based work accounts for approximately 28%[19, 21] Financial Performance & Guidance - The company's revenue growth guidance for 2025 is between $2.8 billion and $2.95 billion[47] - GAAP EPS guidance for 2025 is $1.97 to $2.02[47] - Adjusted diluted EPS guidance for 2025 is $3.60 to $3.65[47] - The company anticipates an earnout spend for previous acquisitions of approximately $60 million in 2025[47] Growth Strategy - The company aims for long-term revenue growth of 8% to 10%[31] - The company aims for long-term earnings growth of 1.5x to 2x[30]
Bausch Health(BHC) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Financial Performance - Bausch Health (excl B+L) achieved its 10th consecutive quarter of revenue and Adjusted EBITDA growth[18] - BHC (Excl B+L) reported revenue growth of 7% and organic revenue growth of 5% in 3Q25, reaching $1400 million[20] - BHC (Excl B+L) Adjusted EBITDA increased by 7% in 3Q25, including an $81 million Acquired IPR&D charge, reaching $773 million[21] - Consolidated revenue increased by 7% to $2681 million in 3Q25, with organic growth of 5%[26, 27] - Adjusted EBITDA attributable to Bausch Health Companies Inc increased by 8% to $986 million in 3Q25[27] - Adjusted Cash Flow from Operations was $508 million[27] Segment Performance - Salix segment reported revenue of $716 million, a 12% increase, with Xifaxan contributing significantly to growth[41, 42] - Solta Medical segment revenue increased by 25% to $140 million, driven by volume expansion across all geographies[55, 56] - Bausch + Lomb reported revenue of $1281 million, a 7% increase, with single-digit growth across all business segments[67] Guidance - The company raised its full-year 2025 Adjusted Operating Cash Flow guidance for Bausch Health (Excl B+L) to $0975 - $1025 billion[74]
Moelis & pany(MC) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Business Overview - Moelis & Company is presented as a leading global advisory-focused independent investment bank [6] - The firm emphasizes a client-first philosophy, diversified capabilities, and a robust financial model [4] - Moelis has a global reach, advising clients in over 45 countries [7] Financial Performance - The company returned approximately $2.9 billion in capital to shareholders [7, 66] - Moelis achieved revenue growth of 187% from FY 2014 to LTM 3Q 2025 [7] - LTM 3Q 2025 Revenue was $1,487 million [7] Talent and Global Presence - The firm has 170 Managing Directors, with approximately 40% being internally promoted [7] - Moelis has 1,430 employees across 23 locations globally [7] - The company provides world-class advice across major industries and sub-sectors [15] Capital Structure Advisory - Moelis has restructured approximately $1.0 trillion of liabilities since its IPO in 2014 [27] - Approximately 60% of engagements are company-side, and 50% are completed out-of-court [28, 29] - Moelis Capital Structure Advisory has been ranked a top 3 advisor over the last decade [31] Capital Markets - The company has raised approximately $200 billion in capital since its IPO [37] Shareholder Returns - Total shareholder return is approximately 500% [7] - Moelis's indexed total shareholder return is 516% since its IPO in April 2014 [74]
Verra Mobility(VRRM) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Financial Performance - Total revenue reached $262 million, a 16% year-over-year increase[6] - Adjusted EBITDA was $113 million, reflecting an 8% year-over-year growth[6] - Adjusted EPS increased to $037, a 16% year-over-year growth[6] - Free Cash Flow stood at $49 million, with a 43% Free Cash Flow conversion of Adjusted EBITDA[6] Segment Highlights - Government Solutions service revenue grew by 19% year-over-year, driven by red-light camera installations and 11% growth outside of New York City[9] - Commercial Services revenue increased by 7% year-over-year due to increased travel volume, product adoption, and tolling activity[9] - Parking Solutions SaaS and Services revenue grew by 3% year-over-year, driven by increased professional services and SaaS recurring revenue[9] Strategic Initiatives and Outlook - The Board of Directors authorized a $150 million increase to the existing stock repurchase program[9] - The company is increasing its 2025 revenue guidance, driven by the New York City expansion[9] - The New York City Department of Transportation red-light camera expansion program includes a change order authorizing the installation of up to 250 additional red-light cameras in 2025[9] - The company anticipates a total contract value of $963 million over the next 5 years from the New York City contract[45]
Stem(STEM) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
October 29, 2025 Third Quarter 2025 Financial Results Cautionary Statement Regarding Forward-Looking Statements This presentation, as well as other statements we make, contains "forward-looking statements" within the meaning of the federal securities laws, which include any statements that are not historical facts. Such statements often contain words such as "expect," "may," "can," "believe," "predict," "plan," "potential," "projected," "projections," "forecast," "estimate," "intend," "anticipate," "ambitio ...
Teladoc(TDOC) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Financial Performance - Q3 2025 - Revenue for 3Q-25 was $626 million, a decrease of 2% year-over-year[4] - Net loss per share for 3Q-25 was $(0.28)[4] - Adjusted EBITDA for 3Q-25 was $69.9 million, a decrease of 16% year-over-year[4] Financial Outlook - FY25 - The company projects FY-25 revenue to be in the range of $2,510 million to $2,539 million[5] - The company projects FY-25 net loss per share to be in the range of $(1.25) to $(1.10)[5] - The company projects FY-25 Adjusted EBITDA to be in the range of $270 million to $287 million[5] Financial Outlook - Q4 2025 - The company projects 4Q-25 revenue to be in the range of $622 million to $652 million[5] - The company projects 4Q-25 net loss per share to be in the range of $(0.25) to $(0.10)[5] - The company projects 4Q-25 Adjusted EBITDA to be in the range of $73 million to $90 million[5] Balance Sheet and Cash Flow - Cash and cash equivalents as of September 30, 2025, were $726 million[36] - Convertible senior notes as of September 30, 2025, were $994 million[36] - Operating cash flow for 3Q-25 was $99 million[36] - Free cash flow for 3Q-25 was $68 million[36]
Morningstar(MORN) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Q3 2025 Financial Performance - Revenue increased to $617.4 million, representing an 8.4% reported increase and a 9.0% organic increase[13] - Adjusted Operating Income increased to $150.6 million, compared to $130.3 million in Q3 24[13] - Free Cash Flow increased to $160.1 million, a 2.8% increase from $155.8 million in Q3 24[13] - The Adjusted Operating Margin was 24.4%[102] Segment Performance - Morningstar Direct Platform revenue reached $211.1 million, with a 6.3% reported increase and a 6.2% organic increase; Adjusted Operating Income was $93.7 million[49] - PitchBook revenue reached $169.0 million, with a 7.9% reported increase and a 7.7% organic increase; Adjusted Operating Income was $52.9 million[58] - Morningstar Credit revenue reached $91.1 million, with a 28.5% reported increase and a 27.0% organic increase; Adjusted Operating Income was $28.1 million[67] - Morningstar Wealth revenue reached $62.1 million, with a 0.5% reported increase and a 9.8% organic increase; Adjusted Operating Income was $3.1 million[81] - Morningstar Retirement revenue reached $34.2 million, with a 7.5% reported and organic increase; Adjusted Operating Income was $16.9 million[93] Cash Flow and Capital Allocation - Operating Cash Flow was $195.7 million[26] - Capital Allocation included $170.1 million in share repurchases, $35.6 million in capital expenditures, and $19.2 million in dividends paid[27]
Pitney Bowes(PBI) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Pitney Bowes Third Quarter Earnings October 29, 2025 Forward-Looking Statements and Financial Presentation This document contains "forward-looking statements" about the Company's expected or potential future business and financial performance, including, but not limited to, statements about future revenue and profitability, earnings guidance, future events or conditions, capital allocation strategy, expected cost savings and efficiency improvements, and strategic initiatives and priorities. Forward-looking ...
Rogers (ROG) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Q3 2025 Financial Performance - Net sales reached $216 million, an increase from $202.8 million in Q2 2025 [13] - Adjusted EBITDA increased to $37.2 million, compared to $23.9 million in Q2 2025 [13] - Adjusted EBITDA margin improved significantly to 17.2%, up from 11.8% in the previous quarter [6, 13] - Adjusted earnings per diluted share rose to $0.90, a substantial increase from $0.34 in Q2 2025 [13] Sales by End Market (Q3 2025) - Industrial sector accounted for 28% of sales, showing growth in all regions [12] - Aerospace & Defense (A&D) contributed 16% of sales, driven by North American commercial aerospace demand [12] - E-mobility represented 14% of sales, remaining consistent with the previous quarter [12] - Portable electronics accounted for 9% of sales, experiencing double-digit growth due to normal seasonality [12] Q4 2025 Guidance - The company projects net sales between $190 million and $205 million [23] - Gross margin is expected to be in the range of 30% to 32% [23] - Adjusted earnings per diluted share are forecasted to be between $0.40 and $0.80 [23]
Carlisle(CSL) - 2025 Q3 - Earnings Call Presentation
2025-10-29 21:00
Third Quarter 2025 Earnings Call October 29, 2025 Forward Looking Statements & Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," "forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made ...